Thermo Fisher Points to Improving End-Market Activity
Thermo Fisher Scientific Inc. (NYSE: TMO ) on Thursday reported second-quarter adjusted earnings of $6.03 per share, beating the street view of $5.71. The life science giant’s quarterly sales of $11.994 billion increased 10% year-over-year, beating the analyst consensus estimate of $11.701 billion. Organic revenue grow